Fund Holdings — Prosight Management, LP

Total Portfolio Value:
$416.49M
Total Bought:
$90.52M
Total Sold:
$134.77M
Net Transaction:
-$44.25M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Lakefront Biotherapeutics NVADR(LKFT)1,773,6491,150,000-623,649$49.64M$39.84M9.56%-$9.81M
MeiraGTx Holdings plc(MGTX)4,587,4234,089,509-497,914$29.91M$33.66M8.08%+$3.75M
ADC Therapeutics SASHS(ADCT)10,467,7717,472,303-2,995,468$28.05M$29.89M7.18%+$1.84M
Kura Oncology, Inc.(KURA)3,181,1842,758,516-422,668$18.36M$24.41M5.86%+$6.06M
Intuitive Surgical, Inc.(ISRG)048,711+48,711$0$21.79M5.23%+$21.79M
Janux Therapeutics, Inc.(JANX)853,904865,350+11,446$19.73M$21.15M5.08%+$1.42M
Roivant Sciences Ltd.SHS(ROIV)1,808,5391,335,500-473,039$20.38M$20.21M4.85%-$176.1K
ICON Public Limited CompanySHS(ICLR)98,558109,500+10,942$14.34M$19.16M4.60%+$4.83M
Syndax Pharmaceuticals, Inc.(SNDX)1,079,6731,003,400-76,273$10.11M$15.44M3.71%+$5.33M
BridgeBio Pharma, Inc.(BBIO)472,687264,500-208,187$20.41M$13.74M3.30%-$6.67M
Crinetics Pharmaceuticals In298,123328,684+30,561$8.57M$13.69M3.29%+$5.12M
Amicus Therapeutics Inc
COM
3,480,0441,709,533-1,770,511$19.94M$13.47M3.23%-$6.47M
DexCom, Inc.(DXCM)70,000195,217+125,217$6.11M$13.14M3.15%+$7.03M
Shattuck Labs, Inc.(STTK)6,638,9355,451,195-1,187,740$5.26M$13.03M3.13%+$7.77M
Zymeworks Inc.(ZYME)1,309,904749,611-560,293$16.44M$12.80M3.07%-$3.64M
Concentra Group Holdings Parent, Inc.(CON)312,105610,000+297,895$6.42M$12.77M3.07%+$6.35M
Immunovant, Inc.(IMVT)479,400698,472+219,072$7.67M$11.26M2.70%+$3.59M
Select Med Hldgs Corp353,820874,915+521,095$5.37M$11.23M2.70%+$5.86M
Biohaven Ltd.(BHVN)539,071600,000+60,929$7.61M$9.01M2.16%+$1.40M
Vertex Pharmaceuticals Incorporated(VRTX)020,500+20,500$0$8.03M1.93%+$8.03M
Boston Scientific Corporation(BSX)076,100+76,100$0$7.43M1.78%+$7.43M
CareDx, Inc.(CDNA)302,808504,030+201,222$5.92M$7.33M1.76%+$1.41M
Acadia Healthcare Company, Inc.(ACHC)211,816250,000+38,184$4.81M$6.19M1.49%+$1.38M
Tectonic Therapeutic, Inc.(TECX)442,056379,254-62,802$8.78M$5.95M1.43%-$2.83M
OrthoPediatrics Corp.(KIDS)73,647308,707+235,060$1.58M$5.72M1.37%+$4.14M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)579,893343,400-236,493$4.00M$4.34M1.04%+$342.7K
Rocket Pharmaceuticals, Inc.(RCKT)1,580,5881,267,965-312,623$3.87M$4.13M0.99%+$261.1K
PROCEPT BioRobotics Corporation(PRCT)076,991+76,991$0$2.75M0.66%+$2.75M
Align Technology Inc019,442+19,442$0$2.43M0.58%+$2.43M
argenx SEADR(ARGX)22,0003,300-18,700$12.13M$2.43M0.58%-$9.69M
Twist Bioscience Corporation(TWST)075,000+75,000$0$2.11M0.51%+$2.11M
Akero Therapeutics Inc039,072+39,072$0$1.86M0.45%+$1.86M
CytomX Therapeutics, Inc.(CTMX)3,517,113564,800-2,952,313$7.98M$1.80M0.43%-$6.18M
Sight Sciences, Inc.(SGHT)871,687439,941-431,746$3.60M$1.51M0.36%-$2.09M
OnKure Therapeutics, Inc.CL A(OKUR)159,692267,959+108,267$381.7K$736.9K0.18%+$355.2K
Schrödinger, Inc.(SDGR)034,830+34,830$0$698.7K0.17%+$698.7K
Rein Therapeutics Inc.(RNTX)427,919567,898+139,979$599.1K$650.2K0.16%+$51.2K
TrueBlue, Inc.(TBI)079,476+79,476$0$487.2K0.12%+$487.2K
Prothena Corp PlcSHS
SHS
267,80020,000-247,800$1.63M$195.2K0.05%-$1.43M
Pliant Therapeutics, Inc.(PLRX)837,40020,487-816,913$971.4K$30.3K0.01%-$941.1K
Actuate Therapeutics Ord0885+885$0$5.9K0.00%+$5.9K
Axogen, Inc.(AXGN)282,8090-282,809$3.07M$0—-$3.07M
Erasca, Inc.(ERAS)240,2950-240,295$305.2K$0—-$305.2K
Lantheus Holdings, Inc.(LNTH)34,5760-34,576$2.83M$0—-$2.83M
LivaNova PLCSHS(LIVN)140,0000-140,000$6.30M$0—-$6.30M
Mirum Pharmaceuticals, Inc.(MIRM)200,0000-200,000$10.18M$0—-$10.18M
Mural Oncology Pub Ltd Co900,0000-900,000$2.22M$0—-$2.22M
PepGen Inc.(PEPG)243,9800-243,980$270.8K$0—-$270.8K
UnitedHealth Group Incorporated(UNH)110,0000-110,000$34.32M$0—-$34.32M
Page 1 of 1
Prosight Management, LP — 13F Holdings — Q3 2025 | TickerTrail